Takata, Saburo <br/><br/>
STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Jan 2012 
 - 24-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2011.05.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Adenocarcinoma of Lung<br/>Adenocarcinoma, Bronchiolo-Alveolar--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Cell Line, Tumor<br/>Disease Progression<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Immunohistochemistry--methods<br/>Janus Kinase 2--antagonists & inhibitors<br/>Lung Neoplasms--genetics<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Middle Aged<br/>Mitogen-Activated Protein Kinase Kinases--genetics<br/>Neoplasm Invasiveness<br/>Proto-Oncogene Proteins c-akt--genetics<br/>STAT3 Transcription Factor--antagonists & inhibitors